Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.

Published in: Alimentary pharmacology & therapeutics (2021)

Immunomodulators and biologics prescribed in patients with IBD do not appear to increase the severity of COVID-19 infection.

Keyphrases